“Encore Medical EMPOWR 3D Knee Insert May Cause Surgical Delay.” GovInfoNow, updated August 18, 2026. https://govinfonow.com/recall/53318-encore-medical-empowr-3d-knee-insert-may-cause-surgical-delay. Based on FDA recall #Z-0761-2025 (https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-0761-2025%22&limit=1).
The FDA announced on Dec. 10, 2024, that Encore Medical, LP is recalling the EMPOWR 3D Knee Tibial Insert because packages may contain an acetabular system. This error may cause surgical delays while obtaining a replacement product.
How to tell if you have it
Brand: Encore Medical
Product: EMPOWR 3D Knee Tibial Insert, 6R 10MM, VE
REF: 342-10-706
UDI-DI: 00888912167338
Lot: 076T1273A
Quantity: 9 units
Sold: US Nationwide in IN, KS, CA, FL, NY, TX, AL, WA
The hazard
The knee insert package may contain an acetabular system. This mix-up may cause surgical delay to get a new product.
Context
GovInfoNow's records show Encore Medical, LP has issued 43 other recalls since May 31, 2017. Recent company actions include the Feb. 16, 2026 EMPOWR 3D Knee Ins Product Mix-Up Recall and the Jan. 15, 2026 RSP Humeral Socket Insert Recall for incorrect labeling. Other recent recalls of similar products include the May 20, 2026 U2 Total Knee System assembly risk and the May 19, 2026 Depuy ATTUNE Revision Hinge sterility risks.
How to tell if you have this one
Check for the model number 6R 10MM, part number REF: 342-10-706, and lot number 076T1273A on the packaging. The product was sold with a UDI-DI code 00888912167338.
Brand
Encore Medical
Category
Medical device
Based on the official FDA remedy
What to do — step by step
Check Package Details
Look for the model number 6R 10MM, part number REF: 342-10-706, and lot number 076T1273A on the packaging.
Where it went and when
Where it was distributed
Distributed nationwide; the notice names 8 states.
Named in the notice
Covered by “nationwide”
Not listed
FDA distribution: “US Nationwide distribution in the states of IN, KS, CA, FL, NY, TX, AL, WA.” States read from FDA’s own wording; “not listed” means the notice does not name it.
Named in the notice: Alabama, California, Florida, Indiana, Kansas, New York, Texas, Washington.
Recall timeline
FDA published this recall 22 days after the firm started it.
1Firm started the recall
2FDA classified it Class II
3Published in FDA’s Enforcement Report
Dates from the agency record only; steps without a date are left out.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
Official source: FDA Recall #Z-0761-2025 (December 10, 2024) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for Z-0761-2025 to see it in context.
Plain-language summary written by qwen3:4b on August 18, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.